- $283.86bn
- $339.84bn
- $54.32bn
- 80
- 39
- 82
- 75
REG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5 (b) - AbbVie Inc
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5 (a) - AbbVie Inc
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5 (b) - AbbVie Inc
AnnouncementREG - BkofA Merrill Lynch Allergan PLC - Form 38.5 (b) - Allergan Plc
AnnouncementREG - BkofA Merrill Lynch Allergan PLC - Form 38.5 (b) - Allergan Plc
AnnouncementREG-BARCLAYS PLC Form 8.3 - ABBVIE INC
AnnouncementREG - Morgan Stanley Smith Allergan PLC - Form 8.3 - ALLERGAN PLC
AnnouncementREG-Norges Bank: Form 8.3 - AbbVie Inc
AnnouncementREG - T.Rowe Price Assoc - Form 8.3 - [AbbVie Inc]
AnnouncementREG-TIAA-CREF Form 8.3 - AbbVie Inc.
AnnouncementREG-BARCLAYS PLC Form 8.3 - ABBVIE INC
AnnouncementREG - T.Rowe Price Assoc - Form 8.3 - [AbbVie Inc]
AnnouncementREG-TIAA-CREF Form 8.3 - AbbVie Inc.
AnnouncementREG-BARCLAYS PLC Form 8.3 - ABBVIE INC - AMENDMENT
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5(b) - AbbVie Inc
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5(a) - AbbVie Inc
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5(b) - AbbVie Inc
AnnouncementREG-Norges Bank: Form 8.3 - AbbVie Inc
AnnouncementREG-BARCLAYS PLC Form 8.3 - Abbvie Inc
Announcement